PENCIL BIOSCIENCES
Live / Allowed — Publication / registration review complete (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99453404
- Mark type
- Design + words
- Filed
- 21 Oct 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Scott Locke
Goods and services
- Class 001 — Chemicals: Biological preparations in the nature of eukaryotic cells, cell lines and bio-production cell lines generated using gene editing and gene modifying engineering for scientific, laboratory, clinical or medical research; reagents, enzymes, plasmids and assays for scientific, genetic and medical research; molecular biology research tools, namely, chemical, biological and biochemical reagents for research purposes; biological preparations in the nature of separate gene editing components including nucleic acid sequences, RNA, mRNA, rRNA, gRNA, protein, nuclease, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory, clinical or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research use, in vitro or in vivo use in biotechnology research, for clinical research and industrial use.
- Class 005 — Pharmaceuticals: Therapeutic and prophylactic pharmaceutical products for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; pharmaceutical substances and preparations for use in the treatment of cancer, genetic diseases, rare diseases, neurodegenerative diseases and diseases of the immune system; enzymes and enzyme preparations for medical use; biologics in the nature of vectors for the delivery of genes to cells, all for medical purposes; genetically modified cells for medical use; biologics in the nature of vectors for the delivery of genes to cells for medical purposes; cell culture media for medical purposes; biologics in the nature of peptides, proteins, nucleic acids, modified nucleic acids, ribonucleotide protein, mRNA or complexes of these molecules for medical use.
- Class 042 — Scientific and technological services: Scientific, pharmaceutical and medical research and development in the field of gene modification, gene editing, gene correction, gene repair, gene modulation, cell therapy, cellular modification and gene therapy; genetic engineering services, biotechnology research services, and scientific advisory services, all relating to cell therapy and gene therapy products; consultancy and advisory services relating to the aforesaid services.
Owner
- Pencil Biosciences Ltd, Macclesfield, Cheshire East, GB
Prior registrations
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Mar 2026 — NON-FINAL ACTION E-MAILED
- 07 Mar 2026 — NON-FINAL ACTION WRITTEN
- 06 Mar 2026 — ASSIGNED TO EXAMINER
- 05 Mar 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 05 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Oct 2025 — NEW APPLICATION ENTERED